neurofibromatosis type 2

(redirected from Neurofibromatosis type II)
Also found in: Wikipedia.

Neurofibromatosis type 2 (NF2)

A hereditary condition associated with an increased risk of bilateral acoustic neuromas, other nerve cell tumors and cataracts.
Mentioned in: Acoustic Neuroma
neurofibromatosis type 2 intercranial neoplasms and deafness
References in periodicals archive ?
The researchers conducted animal studies tracking the effects of celecoxib on the growth of cancer cells from a tumour type known as neurofibromatosis type II (NF2).
They are mostly sporadic but there are a few reports of ganglioneuromas associated with neurofibromatosis type II and multiple endocrinologic neoplasia type II.
Auditory brainstem implantation improves speech recognition in neurofibromatosis type II patients.
In the United States, the ABI is approved for use only in patients 12 years or older with neurofibromatosis type II, an inherited disease that causes a non-malignant brain tumor on the hearing nerve, but it has shown limited effectiveness in adults.
The vestibular schwannomas on bilateral side is associated with neurofibromatosis type II.
These findings suggested the presence of schwannomas and led to a presumptive diagnosis of neurofibromatosis type II.
Donna Getz is a member of a family who has been dealing with the effects of neurofibromatosis type II (NF2) for several generations.
This investigational device is designed to activate hearing neurons with more precision than previous devices to improve speech recognition for patients suffering from a hereditary disease called Neurofibromatosis Type II (NF2).
Agenesis of internal carotid artery associated with neurofibromatosis type II.
Like the ABI, the PABI is designed for patients suffering from Neurofibromatosis Type II (NF2), a hereditary disease that can cause profound hearing loss through the growth of bilateral tumors on the vestibular nerves.